淋巴和心力衰竭工作人员的教育需求分析:来自英国在线调查的见解. 第二部分:定量发现
Garry Cooper1, Marie Gabe-Walters2, Ioan Humphries3
1National Research and Innovations Specialist, Lymphoedema Wales Clinical Network, UK.
British journal of community nursing
|September 26, 2025
概括
医疗保健专业人员需要更多的培训和指导来管理心力衰竭和慢性外周或淋巴的患者,特别是在压缩治疗方面.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 医疗保健 专业教育 医疗保健 专业教育
背景情况:
- 管理患有同时存在心力衰竭 (HF) 和慢性外周 oedema 或淋巴 oedema 的患者带来了重大的临床挑战,特别是在压缩疗法方面.
- 有效的管理需要在不同的医疗保健学科之间采取协调的方法.
研究的目的:
- 评估医疗保健专业人员管理同时患有心力衰竭和慢性外周或淋巴瘤的患者的角色,信心水平,培训要求和遵守指南.
- 确定特定的教育需求和首选的学习格式,以改善这一复杂的患者群体的护理.
主要方法:
- 一项英国范围内的服务评估调查分发给了342名医疗保健专业人员.
- 用描述性定量分析来分析调查数据.
主要成果:
- 只有3%的心力衰竭专业人员能够进行压缩疗法,相比之下,有97%的淋巴 edem 治疗师和91%的护士.
- 超过90%的参与者希望接受进一步培训,心力衰竭专家和淋巴瘤工作人员在最近接受的教育方面存在显著的差异.
- 关键的教育重点包括转诊途径和心力衰竭患者的压缩疗法,多学科网络研讨会是首选的学习格式.
结论:
- 需要综合教育和共享护理模式,以改善心力衰竭和慢性外周或淋巴患者的管理.
- 加强压缩指导的传播对于确保对这种多病患者群体提供安全有效的护理至关重要.
相关概念视频
Heart Failure VII: Nursing Interventions
420
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
420
Heart Failure III: Clinical Manifestations
510
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
510
Cardiomyopathy VI: Nursing Management
313
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
313
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Mitral Regurgitation IV: Nursing Management
309
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
309
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223


